Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IF/TA progression after kidney transplantation under tacrolimus-based immunosuppression
NL-OMON24970Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Mar 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of tacrolimus, sirolimus and mycophenolate mofetil in kidney transplant (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Progression in IF/TA. Started Mar 2010; status: active, not recruiting.
02
Drugs
tacrolimussirolimusmycophenolate mofetil
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON24970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24970.